Drug Shortage Report for MYLAN-CLINDAMYCIN
Report ID | 9036 |
Drug Identification Number | 02258331 |
Brand name | MYLAN-CLINDAMYCIN |
Common or Proper name | CLINDAMYCIN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | J01FF |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-05-01 |
Estimated end date | Unknown |
Actual end date | 2018-07-03 |
Shortage status | Resolved |
Updated date | 2018-07-04 |
Company comments | Discontinued in ID 51308 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2018-07-03 | French | Compare |
v22 | 2018-07-04 | English | Compare |